CRL

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.79
Percentage change -0.46	%

Peers: IQV LDOS MEDP CVS PFE ILMN BMY LH MRK

| Held by: VTI VOO VB RSP SPY IVV VBR XLV VBK IBB

Index	S&P 500	P/E	661.99	EPS (ttm)	0.26	Insider Own	1.12%	Shs Outstand	51.14M	Perf Week	0.31%
Market Cap	8.68B	Forward P/E	16.43	EPS next Y	10.33	Insider Trans	-0.77%	Shs Float	50.57M	Perf Month	9.62%
Income	15.93M	PEG	174.21	EPS next Q	2.11	Inst Own	105.02%	Short Float	5.80%	Perf Quarter	-15.84%
Sales	4.05B	P/S	2.14	EPS this Y	-8.97%	Inst Trans	1.91%	Short Ratio	2.73	Perf Half Y	-10.64%
Book/sh	67.69	P/B	2.51	EPS next Y	9.98%	ROA	0.20%	Short Interest	2.93M	Perf Year	-35.46%
Cash/sh	3.99	P/C	42.54	EPS next 5Y	3.80%	ROE	0.45%	52W Range	150.79 - 274.77	Perf YTD	-8.02%
Dividend Est.	-	P/FCF	17.31	EPS past 5Y	-47.65%	ROI	0.26%	52W High	-38.20%	Beta	1.38
Dividend TTM	-	Quick Ratio	1.13	Sales past 5Y	9.37%	Gross Margin	31.35%	52W Low	12.61%	ATR (14)	5.86
Dividend Ex-Date	-	Current Ratio	1.41	EPS Y/Y TTM	-96.95%	Oper. Margin	13.81%	RSI (14)	52.83	Volatility	4.60% 3.43%
Employees	20100	Debt/Eq	0.80	Sales Y/Y TTM	-1.92%	Profit Margin	0.39%	Recom	2.79	Target Price	176.20
Option/Short	Yes / Yes	LT Debt/Eq	0.79	EPS Q/Q	-216.39%	Payout	0.00%	Rel Volume	0.58	Prev Close	170.59
Sales Surprise	1.92%	EPS Surprise	5.24%	Sales Q/Q	-1.08%	Earnings	Feb 19 BMO	Avg Volume	1.07M	Price	169.80
SMA20	2.65%	SMA50	0.47%	SMA200	-12.43%	Trades		Volume	535,062	Change	-0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-25	Upgrade	Citigroup	Sell → Neutral	$155 → $175
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral	$188
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Jan-17-25	Downgrade	UBS	Buy → Neutral	$250 → $185
Nov-18-24	Downgrade	CLSA	Hold → Underperform	$164
Nov-07-24	Upgrade	CLSA	Underperform → Hold	$205
Oct-23-24	Initiated	CLSA	Underperform	$167
Oct-14-24	Initiated	Redburn Atlantic	Sell
Oct-07-24	Downgrade	Evercore ISI	Outperform → In-line	$225 → $190
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$250 → $215
Oct-01-24	Downgrade	Citigroup	Neutral → Sell	$215 → $175
Aug-08-24	Downgrade	Robert W. Baird	Outperform → Neutral	$239 → $191
Aug-08-24	Downgrade	JP Morgan	Overweight → Neutral	$270 → $205
Jun-28-24	Downgrade	Argus	Buy → Hold
Jun-07-24	Initiated	Mizuho	Neutral	$235
Jun-06-24	Initiated	Goldman	Buy	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Sep-13-23	Initiated	TD Cowen	Market Perform	$212
Jul-10-23	Downgrade	Citigroup	Buy → Neutral	$260 → $225
Feb-23-23	Upgrade	Guggenheim	Neutral → Buy	$255

Show Previous Ratings

Mar-11-25 08:00AM	Charles River Laboratories to Present at Barclays Global Healthcare Conference (Business Wire)
Mar-05-25 04:01AM	Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 (StockStory)
Feb-28-25 09:35AM	Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings (Insider Monkey)
Feb-25-25 11:30AM	SGH and Charles River team up for CGMP cell banking services (Hospital Management)
08:00AM	Charles River Announces Agreement with Singapore General Hospital (Business Wire)
09:15AM	Loading…
Feb-24-25 09:15AM	Deciphering Charles River (CRL) International Revenue Trends (Zacks)
08:03AM	UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-20-25 02:04AM	Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
12:11AM	Q4 2024 Charles River Laboratories International Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 06:08PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) +6.87%
04:58PM	Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance (Benzinga)
09:30AM	Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics (Zacks)
08:10AM	Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:27AM	Charles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4 (StockStory)
07:22AM	Charles River: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance (Business Wire)
Feb-18-25 08:03AM	Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow (StockStory)
Feb-17-25 09:16AM	Gear Up for Charles River (CRL) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Feb-12-25 10:00AM	Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-11-25 06:41PM	Charles River Laboratories International, Inc. (CRL) Expands AI-Powered Digital Pathology Collaboration with Deciphex (Insider Monkey)
08:00AM	Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions (Business Wire)
Jan-28-25 04:30PM	Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call (Business Wire)
Jan-23-25 07:16AM	Charles River downgraded to Market Perform from Outperform at William Blair (TipRanks)
Jan-21-25 09:09AM	RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL) (Insider Monkey)
08:27AM	What Makes Charles River Labs (CRL) an Investment Bet? (Insider Monkey)
08:00AM	Charles River Expands Apollo Ecosystem, Offering Bespoke Client Experiences (Business Wire)
Jan-17-25 07:22AM	Charles River and Akron link to integrate cytokines into cell therapy (Pharmaceutical Technology)
Jan-16-25 08:00AM	Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform (Business Wire)
Jan-15-25 08:07PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
04:13PM	Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan (Pharmaceutical Technology)
11:56AM	Loading…
Jan-14-25 11:56AM	Top Stock Movers Now: United Rentals, KB Home, Eli Lilly, and More (Investopedia) -6.34%
Jan-13-25 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (Business Wire)
Jan-07-25 08:00AM	Deciphex Secures $32.3M Series C to Address Global Pathology Shortage (Business Wire)
Dec-06-24 11:31AM	Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report? (Zacks)
Dec-05-24 08:00AM	Charles River Introduces Global Biotech Incubator Program (Business Wire)
Dec-02-24 08:00AM	Charles River Laboratories to Present at Evercore ISI Investor Conference (Business Wire)
Nov-11-24 09:15AM	Charles River (CRL) International Revenue in Focus: Trends and Expectations (Zacks)
08:00AM	Charles River Laboratories to Present at UBS and Jefferies Conferences (Business Wire)
Nov-07-24 04:20AM	Q3 2024 Charles River Laboratories International Inc Earnings Call (Thomson Reuters StreetEvents)
02:19AM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
02:14AM	Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
12:02AM	Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight (GuruFocus.com)
Nov-06-24 09:30AM	Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +13.53%
08:10AM	Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:08AM	Charles River: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Third-Quarter 2024 Results (Business Wire)
Nov-04-24 09:16AM	Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-30-24 10:01AM	Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-29-24 12:10PM	Why Charles River (CRL) is Poised to Beat Earnings Estimates Again (Zacks)
Oct-21-24 07:45AM	FibroBiologics and Charles River link for chronic disease therapies manufacture (Pharmaceutical Technology)
Oct-17-24 08:00AM	Charles River Launches New Retrogenix Non-Human Protein Library (Business Wire)
Oct-16-24 04:30PM	Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call (Business Wire)
Oct-03-24 08:00AM	Charles River Provides Translational Expertise at Neuroscience 2024 (Business Wire)
Oct-02-24 08:00AM	Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease (Business Wire)
Sep-17-24 08:00AM	Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research (Business Wire)
Sep-06-24 11:31AM	Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report? (Zacks)
10:05AM	Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL) (Insider Monkey)
Sep-04-24 09:21AM	Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience (PR Newswire)
Sep-03-24 04:30PM	Charles River Laboratories to Present at Baird and Morgan Stanley Conferences (Business Wire)
Aug-28-24 04:46AM	Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment (Insider Monkey)
Aug-19-24 06:53AM	Terumo and Charles River demonstrate effectiveness of CGT manufacturing device (Medical Device Network)
Aug-12-24 07:01PM	Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL) (GuruFocus.com)
09:15AM	Why Charles River (CRL) International Revenue Trends Deserve Your Attention (Zacks)
Aug-09-24 01:49PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
Aug-08-24 06:30AM	Big Pharma Cuts R&D, Sending Shudders Through Industry (The Wall Street Journal)
01:04AM	Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight (GuruFocus.com)
01:03AM	Q2 2024 Charles River Laboratories International Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 08:35PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -12.60%
05:36PM	S&P 500 Gains and Losses Today: Fortinet Stock Surges on Earnings Beat (Investopedia)
04:15PM	Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 (Investor's Business Daily)
01:30PM	Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down (Zacks)
01:06PM	Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling (Investopedia)
09:30AM	Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings (Zacks)
08:10AM	Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:07AM	Charles River: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Second-Quarter 2024 Results (Business Wire)
Aug-05-24 09:16AM	Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jul-30-24 07:28PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
08:00AM	Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development (Business Wire)
Jul-24-24 08:43AM	Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings (Zacks)
08:00AM	Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery (Business Wire)
Jul-16-24 04:30PM	Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call (Business Wire) +5.11%
Jul-09-24 09:38AM	Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy (Zacks)
Jul-08-24 08:00AM	Charles River to Perform Plasmid Manufacturing for AAVantgarde (Business Wire)
Jul-05-24 09:23AM	Charles River (CRL) Could be an Apt Pick Right Now: Here's Why (Zacks)
Jun-27-24 10:23AM	Charles River's (CRL) RMS Growth Aids Amid FX Headwind (Zacks)
Jun-26-24 07:46AM	Charles River (CRL) Inks CDMO Deal With Gates Institutes (Zacks)
Jun-25-24 08:00AM	Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus (Business Wire)
Jun-18-24 08:49AM	The CRO Sector Looks Appealing, Says Goldman Sachs Here Are 2 Stocks to Consider (TipRanks)
07:53AM	Charles River (CRL) Advances in T-Cell Therapy With New Alliance (Zacks)
04:52AM	Charles River and Captain T Cell sign vector production agreement (Pharmaceutical Technology)
Jun-17-24 08:00AM	Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy (Business Wire)
Jun-11-24 08:13AM	Charles River (CRL) Partners to Reduce Animal Research Usage (Zacks)
08:00AM	Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives (Business Wire)
Jun-06-24 08:00AM	Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville (Business Wire)
Jun-04-24 08:00AM	Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research (Business Wire)
Jun-03-24 08:00AM	Charles River Laboratories to Present at William Blair and Jefferies Conferences (Business Wire)
May-31-24 10:42AM	Charles River (CRL) Launches Viral Vector Tech Transfer Program (Zacks)
May-30-24 08:00AM	Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development (Business Wire)
07:17AM	Reasons to Hold Charles River (CRL) in Your Portfolio Now (Zacks)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FOSTER JAMES C	Chairman, President and CEO	Feb 20 '25	Buy	165.01	6,075	1,002,436	183,639	Feb 21 04:41 PM
Girshick Birgit	Corporate Executive VP & COO	Feb 20 '25	Buy	164.63	1,514	249,250	55,058	Feb 21 04:38 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 20 '25	Sale	162.50	4,400	715,000	20,013	Feb 21 04:36 PM
Joseph LaPlume	Officer	Feb 20 '25	Proposed Sale	165.00	4,400	726,000		Feb 20 12:36 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.12	6,621	1,430,918	12,386	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Sale	216.50	1,000	216,500	0	Nov 12 04:38 PM
WALLMAN RICHARD F	Director	Nov 07 '24	Proposed Sale	216.01	12,161	2,626,923		Nov 07 04:23 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 08 '24	Sale	199.36	1,780	354,861	22,521	Aug 12 04:13 PM
Joseph LaPlume	Officer	Aug 08 '24	Proposed Sale	196.63	1,780	350,000		Aug 08 01:34 PM
FOSTER JAMES C	Chairman, President and CEO	Aug 01 '24	Sale	250.00	25,000	6,250,000	188,251	Aug 05 04:04 PM
FOSTER JAMES C	Officer	Aug 01 '24	Proposed Sale	250.00	25,000	6,250,000		Aug 01 04:07 PM
MASSARO GEORGE	Director	May 15 '24	Sale	235.62	332	78,225	5,855	May 16 04:35 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 10 '24	Sale	226.97	1,304	295,969	23,276	May 14 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Charles River Laboratories International Inc

Upgrade your FINVIZ experience